An apicobasal gradient of Rac activity determines protrusion form and position

Each cell within a polarised epithelial sheet must align and correctly position a wide range of subcellular structures, including actin-based dynamic protrusions. Using in vivo inducible transgenes that can sense or modify Rac activity, we demonstrate an apicobasal gradient of Rac activity that is required to correctly form and position distinct classes of dynamic protrusion along the apicobasal axis of the cell. We show that we can modify the Rac activity gradient in genetic mutants for specific polarity proteins, with consequent changes in protrusion form and position and additionally show, using photoactivatable Rac transgenes, that it is the level of Rac activity that determines protrusion form. Thus, we demonstrate a mechanism by which polarity proteins can spatially regulate Rac activity and the actin cytoskeleton to ensure correct epithelial cell shape and prevent epithelial-to-mesenchymal transitions

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

BACKGROUND Patients with elevated triglyceride levels are at increased risk for ischemic events. Icosapent ethyl, a highly purified eicosapentaenoic acid ethyl ester, lowers triglyceride levels, but data are needed to determine its effects on ischemic events. METHODS We performed a multicenter, randomized, double-blind, placebo-controlled trial involving patients with established cardiovascular disease or with diabetes and other risk factors, who had been receiving statin therapy and who had a fasting triglyceride level of 135 to 499 mg per deciliter (1.52 to 5.63 mmol per liter) and a low-density lipoprotein cholesterol level of 41 to 100 mg per deciliter (1.06 to 2.59 mmol per liter). The patients were randomly assigned to receive 2 g of icosapent ethyl twice daily (total daily dose, 4 g) or placebo. The primary end point was a composite of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, coronary revascularization, or unstable angina. The key secondary end point was a composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke. RESULTS A total of 8179 patients were enrolled (70.7% for secondary prevention of cardiovascular events) and were followed for a median of 4.9 years. A primary end-point event occurred in 17.2% of the patients in the icosapent ethyl group, as compared with 22.0% of the patients in the placebo group (hazard ratio, 0.75; 95% confidence interval [CI], 0.68 to 0.83; P<0.001); the corresponding rates of the key secondary end point were 11.2% and 14.8% (hazard ratio, 0.74; 95% CI, 0.65 to 0.83; P<0.001). The rates of additional ischemic end points, as assessed according to a prespecified hierarchical schema, were significantly lower in the icosapent ethyl group than in the placebo group, including the rate of cardiovascular death (4.3% vs. 5.2%; hazard ratio, 0.80; 95% CI, 0.66 to 0.98; P=0.03). A larger percentage of patients in the icosapent ethyl group than in the placebo group were hospitalized for atrial fibrillation or flutter (3.1% vs. 2.1%, P=0.004). Serious bleeding events occurred in 2.7% of the patients in the icosapent ethyl group and in 2.1% in the placebo group (P=0.06). CONCLUSIONS Among patients with elevated triglyceride levels despite the use of statins, the risk of ischemic events, including cardiovascular death, was significantly lower among those who received 2 g of icosapent ethyl twice daily than among those who received placebo. (Funded by Amarin Pharma; REDUCE-IT ClinicalTrials.gov number, NCT01492361

Metal-support interaction in Pd/CeO2 model catalysts for CO oxidation: from pulsed laser-ablated nanoparticles to highly active state of the catalyst

Palladium and cerium oxide nanoparticles obtained by pulsed laser ablation (PLA) in liquid (water or ethanol) have been used as nanostructured precursors for the synthesis of composite Pd/CeO2 catalysts. The initial mixture of Pd and CeO2 nanoparticles does not show catalytic activity at temperatures lower than 100 °C. It has been found that the composites prepared by PLA in alcohol are easily activated by calcination in air at 450–600 °C, demonstrating a high level of activity at room temperature. Application of XRD, TEM and XPS reveals that laser ablation in water leads to the formation of large and well-crystallized nanoparticles of palladium and CeO2, whereas ablation in alcohol results in the formation of much smaller PdCx nanoparticles. The activation of the composites takes place due to the strong Pd–ceria interaction which occurs more easily for highly dispersed defective particles obtained in alcohol. Such an interaction implies the introduction of palladium ions into the ceria lattice with the formation of a mixed phase of PdxCe1−xO2−x−δ solid solution at the contact spaces of palladium and cerium oxide nanoparticles. TPR-CO and XPS data show clearly that on the surface of the PdxCe1−xO2−x−δ solid solution the oxidized PdOx(s)/Pd–O–Ce(s) clusters are formed. These clusters are composed of highly reactive oxygen which is responsible for the high level of catalytic activity in LTO CO

Metal-support interaction in Pd/CeO2 model catalysts for CO oxidation: from pulsed laser-ablated nanoparticles to highly active state of the catalyst

Palladium and cerium oxide nanoparticles obtained by pulsed laser ablation (PLA) in liquid (water or ethanol) have been used as nanostructured precursors for the synthesis of composite Pd/CeO2 catalysts. The initial mixture of Pd and CeO2 nanoparticles does not show catalytic activity at temperatures lower than 100 °C. It has been found that the composites prepared by PLA in alcohol are easily activated by calcination in air at 450–600 °C, demonstrating a high level of activity at room temperature. Application of XRD, TEM and XPS reveals that laser ablation in water leads to the formation of large and well-crystallized nanoparticles of palladium and CeO2, whereas ablation in alcohol results in the formation of much smaller PdCx nanoparticles. The activation of the composites takes place due to the strong Pd–ceria interaction which occurs more easily for highly dispersed defective particles obtained in alcohol. Such an interaction implies the introduction of palladium ions into the ceria lattice with the formation of a mixed phase of PdxCe1−xO2−x−δ solid solution at the contact spaces of palladium and cerium oxide nanoparticles. TPR-CO and XPS data show clearly that on the surface of the PdxCe1−xO2−x−δ solid solution the oxidized PdOx(s)/Pd–O–Ce(s) clusters are formed. These clusters are composed of highly reactive oxygen which is responsible for the high level of catalytic activity in LTO CO